Related Experiment Video

Updated: May 14, 2026

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
11:45

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Cardiac stem cells: A promising treatment option for heart failure

Xiaohui Zhao1, Lan Huang

  • 1Department of Cardiology, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, P.R. China.

Experimental and Therapeutic Medicine
|February 15, 2013
PubMed

Insights

Cardiac stem cells (CSCs) show therapeutic potential for heart failure by promoting cardiomyocyte regeneration after myocardial infarction. This review explores CSC mechanisms and compares rat, mouse, and human CSC efficacy for heart repair.

Area of Science:

  • Cardiovascular Medicine
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Cardiovascular diseases are the leading global cause of mortality.
  • Heart failure often results from cardiomyocyte loss post-myocardial infarction, with limited endogenous repair.
  • Cardiac stem cells (CSCs) are investigated for their therapeutic potential in treating heart failure.

Purpose of the Study:

  • To review the cardioprotective effects of cardiac stem cells (CSCs).
  • To examine the impact of CSCs on cardiomyocyte function.
  • To compare the efficacy of CSCs from different species (rats, mice, humans) for heart failure treatment.

Main Methods:

  • Literature review of studies on cardiac stem cells and myocardial infarction.
  • Analysis of research investigating CSC mechanisms in promoting cardiomyocyte regeneration.
  • Comparative assessment of CSC efficacy across species.

Main Results:

  • CSCs demonstrate the ability to promote cardiomyocyte regeneration in animal models of myocardial infarction.
  • The precise mechanisms underlying CSC-mediated cardiac repair require further elucidation.
  • Variations in CSC efficacy may exist between different species.

Conclusions:

  • Cardiac stem cells represent a promising therapeutic strategy for heart failure.
  • Further research is needed to fully understand CSC mechanisms and optimize their clinical application.
  • Comparative studies highlight the importance of species-specific considerations in CSC-based therapies.

Keywords:
cardiac stem cellscardiomyocyteheart failure

More Related Videos

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Intramyocardial Cell Delivery: Observations in Murine Hearts08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...